CARGO Therapeutics Statistics
Total Valuation
CRGX has a market cap or net worth of $751.55 million. The enterprise value is $373.79 million.
| Market Cap | 751.55M |
| Enterprise Value | 373.79M |
Important Dates
The next estimated earnings date is Tuesday, May 21, 2024, after market close.
| Earnings Date | May 21, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CRGX has 39.37 million shares outstanding. The number of shares has increased by 1,272.07% in one year.
| Shares Outstanding | 39.37M |
| Shares Change (YoY) | +1,272.07% |
| Shares Change (QoQ) | +693.04% |
| Owned by Insiders (%) | 7.26% |
| Owned by Institutions (%) | 64.31% |
| Float | 21.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.85 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.35, with a Debt / Equity ratio of 0.07.
| Current Ratio | 19.35 |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -60.19 |
Financial Efficiency
Return on equity (ROE) is -53.00% and return on invested capital (ROIC) is -22.29%.
| Return on Equity (ROE) | -53.00% |
| Return on Assets (ROA) | -42.40% |
| Return on Capital (ROIC) | -22.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$846,095 |
| Employee Count | 116 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (1Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 22.88 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 40.64 |
| Average Volume (30 Days) | 312,090 |
Short Selling Information
The latest short interest is 3.60 million, so 9.15% of the outstanding shares have been sold short.
| Short Interest | 3.60M |
| Short Previous Month | 3.40M |
| Short % of Shares Out | 9.15% |
| Short % of Float | 16.63% |
| Short Ratio (days to cover) | 3.75 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -96.71M |
| Pretax Income | -98.15M |
| Net Income | -98.15M |
| EBITDA | -92.85M |
| EBIT | -96.54M |
| Earnings Per Share (EPS) | -$16.53 |
Balance Sheet
The company has $406.30 million in cash and $28.54 million in debt, giving a net cash position of $377.76 million or $9.60 per share.
| Cash & Cash Equivalents | 406.30M |
| Total Debt | 28.54M |
| Net Cash | 377.76M |
| Net Cash Per Share | $9.60 |
| Equity / Book Value | 405.39M |
| Book Value Per Share | 10.30 |
| Working Capital | 388.32M |
Cash Flow
In the last 12 months, operating cash flow was -$81.16 million and capital expenditures -$8.28 million, giving a free cash flow of -$89.44 million.
| Operating Cash Flow | -81.16M |
| Capital Expenditures | -8.28M |
| Free Cash Flow | -89.44M |
| FCF Per Share | -$15.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,272.07% |
| Shareholder Yield | -1,272.07% |
| Earnings Yield | -13.06% |
| FCF Yield | -11.90% |
Analyst Forecast
The average price target for CRGX is $29.67, which is 55.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $29.67 |
| Price Target Difference | 55.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |